Description
PRINCIPIO ACTIVO: TRAVOPROST
Características de ECCER:
Infecciones fúngicas en pacientes con inmunosupresión
75 ML Gel Tubo
SYNVISC-ONE 8 mg/6 mL | Solución Intraarticular | Hylan G-F 20 | Sanofi
AFUMIX 37.5/500 MG 4 TAB JOHNSON & JOHNSON SA DE CV PRINCIPIO ACTIVO: TRAVOPROSTPRINCIPIO ACTIVO: FLUCONAZOL TINIDAZOL DOSIS: 500 MG FORMA FARMACUTICA: 4 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
JUEGO DE MESA ¡COMO PICA! PEGI 10 ingles
US$ 31.85
Figura Re-Ment Swing Kirby (al azar) Xbox One
US$ 7495.00
Final Fantasy XVI PS5 rec
US$ 24995.00
GrimGrimoire OnceMore Deluxe Edition NSW FANGAMER
US$ 27495.00
recommand products
